Literature DB >> 7196010

Effects of indomethacin on fetal rat lungs: a possible cause of persistent fetal circulation (PFC).

L C Harker, S E Kirkpatrick, W F Friedman, C M Bloor.   

Abstract

Indomethacin, because of its prostaglandin inhibition, may cause constriction of the ductus arteriosus and affect the pulmonary circulation. To study this possibility, we gave indomethacin daily by gavage to two groups of pregnant rats from the 17th day of pregnancy through delivery (group 1, 2 mg/kg/day; group 2, 4 mg/kg/day). Group 3, untreated control pregnant rats received saline. The pups were killed 30 min after birth and heart-lung preparations were perfused with glutaraldehyde. Appropriate blocks were processed for quantitative morphometry of the pulmonary arteries and arterioles. For analysis, the vessels were grouped by external diameter, i.e., less than 30, 30 to 50, and 50 to 100 micron. Groups 1 and 2 showed an increased medial smooth muscle mass in both 30 to 50 and 50 to 100-micron vessels as indicated by media thickness and medial areas (P less than 0.05). Muscularized arterioles, less than 30 micron, were present in groups 1 and 2, but not in controls. The relative mass of lung parenchymal components were determined by point counting. Indomethacin-treated animals had an increased saccular wall mass, decreased airspace mass, and a decreased capillary to saccular wall ratio (P less than 0.05). These results show that the fetal pulmonary circulation's response to indomethacin comprises the appearance of medial hypertrophy and newly muscularized arterioles. When these changes occur in lungs with immature, thick saccular walls, there is a decreased surface for oxygen exchange and an increased pulmonary vascular resistance resulting in a persistent fetal circulation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7196010     DOI: 10.1203/00006450-198102000-00013

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  6 in total

Review 1.  Treatment of preterm labour. A review of the therapeutic options.

Authors:  S N Caritis
Journal:  Drugs       Date:  1983-09       Impact factor: 9.546

2.  Management of the infant with congenital diaphragmatic hernia (CDH) and persistent pulmonary hypertension (PPHN).

Authors:  C J Stolar; P W Dillon; R P Altman
Journal:  Jpn J Surg       Date:  1985-11

3.  Failure of postnatal adaptation of the pulmonary circulation after chronic intrauterine pulmonary hypertension in fetal lambs.

Authors:  S H Abman; P F Shanley; F J Accurso
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

Review 4.  Non-narcotic analgesics. Use in pregnancy and fetal and perinatal effects.

Authors:  M A Heymann
Journal:  Drugs       Date:  1986       Impact factor: 9.546

Review 5.  Nonsteroidal antiinflammatory drugs in late pregnancy and persistent pulmonary hypertension of the newborn.

Authors:  Linda J Van Marter; Sonia Hernandez-Diaz; Martha M Werler; Carol Louik; Allen A Mitchell
Journal:  Pediatrics       Date:  2012-12-03       Impact factor: 7.124

6.  Altered cardiolipin metabolism is associated with cardiac mitochondrial dysfunction in pulmonary vascular remodeled perinatal rat pups.

Authors:  Laura K Cole; Genevieve C Sparagna; Vernon W Dolinsky; Grant M Hatch
Journal:  PLoS One       Date:  2022-02-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.